PERCEPTIVE VENTURES MANAGEMENT COMPANY, LLC

Thesis

Perceptive Advisors is a prominent investment firm with a dedicated focus on the life sciences sector, encompassing biotechnology, pharmaceuticals, medical devices, and diagnostics. Their core investment thesis revolves around identifying and supporting transformative innovations within the life sciences industry, driven by a purpose to bring groundbreaking healthcare concepts to fruition. They meticulously assess biotechnologies for efficacy and potential impact, employing a data-driven, scientific approach and leveraging their team's deep understanding of the bio-medical landscape. Their strategy involves investing across the capital structure, providing both equity and debt financing, as well as structured financings and operational support. Perceptive Advisors actively partners with founders and management teams, often taking a lead or co-lead role in financings, particularly in early-stage ventures, with a particular interest in companies advancing technologies from preclinical stages through clinical proof-of-concept. While headquartered in New York City, they invest globally. The firm's investment preferences span various stages, from pre-seed and seed rounds, particularly through its Perceptive Xontogeny Venture Fund, to Series A, Series B, and later-stage financings, also engaging in private equity and private credit investments. As of March 2025, they reported approximately $8.5 billion in AUM, with more recent reports indicating around $8 billion. The Perceptive Xontogeny Venture Fund II, LP, closed with $515 million in capital commitments. For venture capital investments, they typically target $10 million to $50 million, often leading or co-leading Series A and select growth-stage financings. For its Credit Opportunities Fund, the firm seeks to invest be

Related lists

• Pre-seed investors based in New York, NY
• Seed investors based in New York, NY
• Series A investors based in New York, NY